These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 21029156)
1. Update on the use of melatonin in pediatrics. Gitto E; Aversa S; Reiter RJ; Barberi I; Pellegrino S J Pineal Res; 2011 Jan; 50(1):21-8. PubMed ID: 21029156 [TBL] [Abstract][Full Text] [Related]
2. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Reiter RJ; Acuña-Castroviejo D; Tan DX; Burkhardt S Ann N Y Acad Sci; 2001 Jun; 939():200-15. PubMed ID: 11462772 [TBL] [Abstract][Full Text] [Related]
3. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Reiter RJ; Tan DX; Manchester LC; Qi W Cell Biochem Biophys; 2001; 34(2):237-56. PubMed ID: 11898866 [TBL] [Abstract][Full Text] [Related]
4. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. Gitto E; Pellegrino S; Gitto P; Barberi I; Reiter RJ J Pineal Res; 2009 Mar; 46(2):128-39. PubMed ID: 19054296 [TBL] [Abstract][Full Text] [Related]
6. Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites. Reiter RJ; Tan DX; Jou MJ; Korkmaz A; Manchester LC; Paredes SD Neuro Endocrinol Lett; 2008 Aug; 29(4):391-8. PubMed ID: 18766165 [TBL] [Abstract][Full Text] [Related]
7. Melatonin: reducing molecular pathology and dysfunction due to free radicals and associated reactants. Reiter RJ; Tan DX; Allegra M Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():3-8. PubMed ID: 12019343 [TBL] [Abstract][Full Text] [Related]
8. Melatonin as pharmacologic support in burn patients: a proposed solution to thermal injury-related lymphocytopenia and oxidative damage. Maldonado MD; Murillo-Cabezas F; Calvo JR; Lardone PJ; Tan DX; Guerrero JM; Reiter RJ Crit Care Med; 2007 Apr; 35(4):1177-85. PubMed ID: 17312564 [TBL] [Abstract][Full Text] [Related]
9. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation. Reiter RJ Front Neuroendocrinol; 1995 Oct; 16(4):383-415. PubMed ID: 8557171 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Reiter RJ; Tan DX; Gitto E; Sainz RM; Mayo JC; Leon J; Manchester LC; Vijayalaxmi ; Kilic E; Kilic U Pol J Pharmacol; 2004; 56(2):159-70. PubMed ID: 15156066 [TBL] [Abstract][Full Text] [Related]
11. Melatonin: action as antioxidant and potential applications in human disease and aging. Bonnefont-Rousselot D; Collin F Toxicology; 2010 Nov; 278(1):55-67. PubMed ID: 20417677 [TBL] [Abstract][Full Text] [Related]
12. Suppression of oxygen toxicity by melatonin. Reiter RJ; Tan DX; Qi WB Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):575-81. PubMed ID: 10437151 [TBL] [Abstract][Full Text] [Related]
13. Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage. Reiter RJ; Tan DX; Manchester LC; Tamura H J Physiol Pharmacol; 2007 Dec; 58 Suppl 6():5-22. PubMed ID: 18212398 [TBL] [Abstract][Full Text] [Related]
14. Melatonin as a radioprotective agent: a review. Vijayalaxmi ; Reiter RJ; Tan DX; Herman TS; Thomas CR Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):639-53. PubMed ID: 15183467 [TBL] [Abstract][Full Text] [Related]